Testing a Resilience Intervention for Individuals Aging With Multiple Sclerosis (MS)

CompletedNot a drug-phase studyMS (type not specified)NCT03177785

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • EverydayMatters

What it measured

Main measures

  • Change in Resilience using Connor Davidson Resilience Scale (brief)

    6 weeks

Other measures (3)

  • Change in positive affect and well being using the Quality of Life in Neurological Disorders (NeuroQoL) Positive Affect and Well-Being Short Form

    6 weeks

    Quality of life (reported by participants)
  • Change in Patient Reported Outcomes Measurement Information System (PROMIS) Satisfaction with Social Roles Short Form

    6 weeks

    Quality of life (reported by participants)
  • Change in disease-management self-efficacy using the University of Washington Self-Efficacy Scale

    6 weeks

Who could take part

MS (type not specified) · 45 and over

Show the full criteria

Inclusion criteria

* 45 years of age * Diagnosis of multiple sclerosis * regular access to the phone and internet * willing to join a moderated group on MSConnection.org

Exclusion criteria

* under 45 years of age * no diagnosis of multiple sclerosis * no access to the phone or internet * unwilling to join moderated group on MSConnection

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

This study aims to test the efficacy of the EverydayMatters Multiple Sclerosis (MS) program for individuals age 45 or older living with multiple sclerosis. The program involves a 6-week telephone-delivered program to promote resilience and happiness for individuals living with MS.

Papers

Loading reviews and guidelines…

History

    1. Started

      Aug 2016

    2. Main results due

      Dec 2016

    3. Finished

      Dec 2016

    Assembled by software from public sources.